HCTZ Peds (hydrochlorothiazide pediatric)

HCTZ Peds (hydrochlorothiazide pediatric) is filed as Thiazide Diuretic. The sections below restate public label fields stored for this profile.

Class
Thiazide Diuretic
Generic name
hydrochlorothiazide pediatric
Route
ORAL
Dosage forms
HOW SUPPLIED Product: 50090-6931 NDC: 50090-6931-0 90 TABLET in a BOTTLE
Manufacturer
A-S Medication Solutions

Approved uses

Hydrochlorothiazide capsules, USP are indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combination diuretic products, hydrochlorothiazide capsules, USP may be used in those patients in whom the development of hyperkalemia cannot be risked, including patients taking ACE inhibitors. Usage in Pregnancy: The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. Edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy. Diuretics are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy. Dependent edema in pregnancy resulting from restriction of venous return by the expanded uterus is properly treated through elevation of the lower extremities and use of support hose; use of diuretics to lower intravascular volume in this case is illogical and unnecessary. There is hypervolemia during normal pregnancy which is harmful to neither the fetus nor the mother (in the absence of cardiovascular disease), but which is associated with edema, including generalized edema in the majority of pregnant women. If this edema produces discomfort, increased recumbency will often provide relief. In rare instances this edema may cause extreme discomfort which is not relieved by rest. In these cases a short course of diuretics may provide relief and may be appropriate.

How it works

Hydrochlorothiazide blocks the reabsorption of sodium and chloride ions, and it thereby increases the quantity of sodium traversing the distal tubule and the volume of water excreted. A portion of the additional sodium presented to the distal tubule is exchanged there for potassium and hydrogen ions. With continued use of hydrochlorothiazide and depletion of sodium, compensatory mechanisms tend to increase this exchange and may produce excessive loss of potassium, hydrogen and chloride ions. Hydrochlorothiazide also decreases the excretion of calcium and uric acid, may increase the excretion of iodide and may reduce glomerular filtration rate. Metabolic toxicities associated with excessive electrolyte changes caused by hydrochlorothiazide have been shown to be dose-related.

Warnings and precautions

Acute Myopia and Secondary Angle-Closure Glaucoma: Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation. Untreated acute angle-closure glaucoma can lead to permanent vision loss. The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible. Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled. Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy. Diabetes and Hypoglycemia: Latent diabetes mellitus may become manifest and diabetic patients given thiazides may require adjustment of their insulin dose. Renal Disease: Cumulative effects of the thiazides may develop in patients with impaired renal function. In such patients, thiazides may precipitate azotemia.

Contraindications

Hydrochlorothiazide is contraindicated in patients with anuria. Hypersensitivity to this product or other sulfonamide derived drugs is also contraindicated.

Dosage and administration

For Control of Hypertension: The adult initial dose of hydrochlorothiazide capsules, USP is one capsule given once daily whether given alone or in combination with other antihypertensives. Total daily doses greater than 50 mg are not recommended.

Drug interactions

Alcohol, barbiturates, or narcotics: potentiation of orthostatic hypotension may occur. Antidiabetic drugs: (oral agents and insulin) dosage adjustment of the antidiabetic drug may be required. Other antihypertensive drugs: additive effect or potentiation. Cholestyramine and colestipol resins: Cholestyramine and colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively. Corticosteroid, ACTH: intensified electrolyte depletion, particularly hypokalemia. Pressor amines (e.g., norepinephrine): possible decreased response to pressor amines but not sufficient to preclude their use. Skeletal muscle relaxants, nondepolarizing (e.g., tubocurarine): possible increased responsiveness to the muscle relaxant. Lithium: generally should not be given with diuretics. Diuretic agents reduce the renal clearance of lithium and greatly increase the risk of lithium toxicity. Refer to the package insert for lithium preparations before use of such preparations with hydrochlorothiazide capsules. Non-steroidal anti-inflammatory drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics. When hydrochlorothiazide capsules and non-steroidal anti-inflammatory agents are used concomitantly, the patients should be observed closely to determine if the desired effect of the diuretic is obtained. Drug/Laboratory Test Interactions: Thiazides should be discontinued before carrying out tests for parathyroid function (see PRECAUTIONS , General ).

Common questions

What is HCTZ Peds approved to treat?

According to its FDA label, HCTZ Peds (hydrochlorothiazide pediatric) is approved for: Hydrochlorothiazide capsules, USP are indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combination diuretic products, hydrochlorothiazide capsules, USP may be used in those p… For medical advice, please talk to your prescriber or pharmacist.

What class of drug is HCTZ Peds?

HCTZ Peds (hydrochlorothiazide pediatric) belongs to the Thiazide Diuretic class of medications.

What form does HCTZ Peds come in?

The FDA label lists HCTZ Peds (hydrochlorothiazide pediatric) as: HOW SUPPLIED Product: 50090-6931 NDC: 50090-6931-0 90 TABLET in a BOTTLE; oral route. Available strengths and packaging vary by manufacturer.

Does HCTZ Peds have a Boxed Warning?

Our ingest of the FDA label for HCTZ Peds (hydrochlorothiazide pediatric) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

How much does HCTZ Peds cost?

Public CMS NADAC pricing for HCTZ Peds (hydrochlorothiazide pediatric) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.

Is HCTZ Peds currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for HCTZ Peds (hydrochlorothiazide pediatric) in our latest ingest. Recall data can change daily — verify at FDA.gov.

When was HCTZ Peds approved by the FDA?

The FDA record lists the approval date for HCTZ Peds (hydrochlorothiazide pediatric) as 2007-02-27.

Who makes HCTZ Peds?

The FDA label lists A-S Medication Solutions as a labeler/manufacturer of HCTZ Peds (hydrochlorothiazide pediatric). Multiple firms may market generics of the same molecule.

How should HCTZ Peds be stored?

The FDA label states: "Hydrochlorothiazide Capsules, USP contain a white to off white powder filled in size “4” hard gelatin capsules with opaque light blue colored cap and opaque light blue colored body imprinted “SG” on cap and “146” on body…" Follow the packaging insert for the authoritative guidance.

On this site

Related medications in this class or category

Loading full data from Know Your Drugs Institute…